The Delineation and Explication of Palliative Options of Last Resort

  • Ben A. RichEmail author


Palliative options of last resort have become a major focus of ethical debates over improving care of the dying, particularly in the United States. This chapter will explore a broad spectrum of palliative measures that may be considered legitimate approaches to end-of-life pain and suffering, including high-dose opioid analgesia, palliative sedation, lethal prescription (where allowed by law), as well a brief discussion of voluntary active euthanasia (lethal injection). In reviewing palliative options of last resort, this chapter will address related considerations such as debates over proper terminology, the role of intent and causation in making moral judgments about palliative measures, including the Doctrine/Principle/Rule of Double Effect (hereinafter DDE), and the persistence of myths about the risks and benefits associated with palliative measures.


  1. American Academy of Hospice and Palliative Medicine (AAHPM) Position Statements. Statement on palliative sedation. Approved by the Board of Directors on Dec. 5, 2014. Retrieved July 25, 2018 from Scholar
  2. American Medical Association Council on Ethical and Judicial Affairs. (2010). Sedation to unconsciousness in end-of-life care. CEJA report 5-A-08. Retrieved July 25, 2018 from unconsciousness-end-life-care.
  3. Annas, G. J. (1995). How we lie. The Hastings Center Report, 25, S12–S14.CrossRefGoogle Scholar
  4. Assemblee Nationale Quebec Select Committee (2012). Dying with dignity report. Retrieved March 14, 2017 from: taires/commissions/csmd/mandats/Mandat-12989/ index.html.
  5. Baker, D. W. (2017). History of the Joint Commission’s pain standards – Lessons for todays prescription opioid epidemic. JAMA, published online February 23, 2017. Scholar
  6. Battin, M. P. (2008). Pulling the sheet over our eyes. The Hastings Center Report, 38, 27–30.CrossRefGoogle Scholar
  7. Baxter v. Montana. (2009). 224 P.3d 1211, 2009, WL 5155363 (Mont).Google Scholar
  8. Beauchamp, T. L., & Childress, J. F. (2009). Principles of biomedical ethics (6th ed.pp. 177–186).Google Scholar
  9. Bergman v. Chin. (2001). No. H205732-1 (Alameda County Ct., June 13).Google Scholar
  10. Billings, J. A., & Block, S. D. (1996). Slow euthanasia. Journal of Palliative Care, 12, 21–30.CrossRefGoogle Scholar
  11. Canada Criminal Code s. 241.2 2016.Google Scholar
  12. Carter v. Canada, Supreme Court of Canada. Carter v. Canada. (2015). SCC 5.Google Scholar
  13. Cassell, E. J. (1982). The nature of suffering and the goals of medicine. The New England Journal of Medicine, 306, 639–645.CrossRefGoogle Scholar
  14. Cassell, E. J. (2004). The nature of suffering and the goals of medicine. New York: Oxford University Press.CrossRefGoogle Scholar
  15. Cassell, E. J., & Rich, B. A. (2010). Intractable end-of-life suffering and the ethics of palliative sedation. Pain Medicine, 11, 435–438.CrossRefGoogle Scholar
  16. Cherney, N. I., Radbruch, L., & Board of the European Association for Palliative Care. (2009). European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliative Medicine, 23, 581–593.CrossRefGoogle Scholar
  17. Chochinov, H. M. (2006). Dying, dignity, and new horizons in palliative end-of-life care. CA: A Cancer Journal for Clinicians, 56, 84–103.Google Scholar
  18. Compassion in Dying v. Washington. (1996). 850 F. Supp. 1454 (W.D. Wash).Google Scholar
  19. Connor, S. R., Pyenson, B., Fitch, K., Spence, C., & Iwaski, K. (2007). Comparing hospice and nonhospice patient survival among patients who die within a three -year window. Journal of Pain and Symptom Management, 33, 238–246.CrossRefGoogle Scholar
  20. Dowell, D., Hagerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain – United States, 2016. JAMA, 315, 1624–1645.CrossRefGoogle Scholar
  21. Education for Physicians on End-of-Life Care. Trainer’s Guide, modol withholding, withdrawing therapy (1999). In: L. L. Emanuel, C. G. von Gunter, & F. D. Ferris. EPEC project.
  22. Estate of Henry James v. Hillhaven Corporation. (1991). No. 89 CVS 64 (N.C. Super. Ct. January 15).Google Scholar
  23. Fishman, S. M. (2007). Responsible opioid prescribing: A physician’s guide. Dallas: Federation of State Medical Boards.Google Scholar
  24. Fox, E. (1997). Predominance of the curative model of medical care – A residual problem. JAMA, 278, 761–763.CrossRefGoogle Scholar
  25. Ganzini, L., Goy, E. R., & Dobscha, S. K. (2008). Prevalence of depression and anxiety in patients requesting physicians’ aid in dying: cross sectional survey. BMJ, 337, a1682.Google Scholar
  26. Gonzales v. Oregon. (2006). 546 U.S. 243.Google Scholar
  27. Institute of Medicine. (1998). Approaching death: Improving care at the end of life. Washington, DC: National Academy Press.Google Scholar
  28. Institute of Medicine. (2014). Dying in America: Improving quality and honoring individual preferences near the end of life. Washington, DC: National Academy Press.Google Scholar
  29. Kissane, D. W., Clark, D. M., & Street, A. F. (2001). Demoralization syndrome – a relevant psychiatric diagnosis for palliative care. Journal of Palliative Care, 17, 12–21.Google Scholar
  30. Kwak, J., & Haley, W. E. (2005). Current research findings on end-of-life decision making among racially or ethnically diverse groups. Gerontologist, 45(3), 634–641.CrossRefGoogle Scholar
  31. Lamb, et al. v. Attorney General of Canada. (2016). No. S165851 Vancouver Registry.Google Scholar
  32. Lewis, P. (2015). Assisted dying: what does the law in different countries say? BBC News. Retrieved March 18, 2017 from:
  33. Lindsay, R. A. (2009). Oregon’s experience: Evaluating the record. The American Journal of Bioethics, 9, 19–27.CrossRefGoogle Scholar
  34. Loggers, E. T., Starks, H., Shannon-Dudley, M., Back, A. L., Appelbaum, F. R., & Steward, F. M. (2013). Implementing a death with dignity program at a comprehensive cancer center. New England Journal of Medicine, 368(15), 1417–1424.CrossRefGoogle Scholar
  35. McIntyre, A. (2004). The double life of double effect. Theoretical Medicine, 25, 61–74.Google Scholar
  36. Miles, S. H. (2004). The hippocratic oath and the ethics of medicine. New York: Oxford University Press.Google Scholar
  37. Miller, F. G., Truog, R. D., & Brock, D. W. (2010). Moral fictions and medical ethics. Bioethics, 24(9), 453–460.CrossRefGoogle Scholar
  38. Myers, F. J., & Linder, J. (2003). Simultaneous care: Disease treatment and palliative care throughout illness. Journal of Clinical Oncology, 21, 1412–1415.CrossRefGoogle Scholar
  39. Nagel, T. (1970). Death. Noûs, 4, 73–80.CrossRefGoogle Scholar
  40. New York Commission on Life and the Law. (1994). When death is sought: assisted suicide and euthanasia in the medical context. Retrieved March 3, 2017 from:\break reports_publications/when_death_is_sought/. Accessed March 3, 2017.
  41. Oregon Death With Dignity Act. (2010). Oregon revised statutes 127.505, et. Seq. Retrieved June 16, 2010, from
  42. Oregon Department of Health Services. (2016). Oregon death with dignity act 2016 data summary. Retrieved March 18, 2017, from https://public. tionResearch/DeathwithDignityAct/Documents/year 19.pdf.
  43. Orentlicher, D., Pope, T. M., & Rich, B. A. (2014). The changing legal climate for physician aid in dying. JAMA, 311(19), 1961–1962.CrossRefGoogle Scholar
  44. Orentlicher, D., Pope, T. M., & Rich, B. A. (2015). Clinical criteria for physician aid in dying. Journal of Palliative Medicine, 18(X). Scholar
  45. Parliament of Canada Report. (2016). Medical assistance in dying: a patient-centered approach. Retrieved March 14, 2017 from: aspx?DocId=8120006.
  46. Pearlman, R. A., Cain, K. C., Patrick, D. L., Appelbaum-Maizel, M., Starks, H. E., Jecker, N. S., et al. (1993). Insights pertaining to patient assessments of states worse than death. The Journal of Clinical Ethics, 4, 33–41.PubMedGoogle Scholar
  47. Pellegrino, E. D. (1998). Emerging ethical issues in palliative care. Journal of American Medical Association, 279, 1521–1522.CrossRefGoogle Scholar
  48. Putman, M. S., Yoon, J. D., Rasinsky, K. A., & Curlin, F. A. (2013). Intentional sedation to unconsciousness at the end of life: Findings from a national physician survey. Journal of Pain and Symptom Management, 46(3), 326–334.CrossRefGoogle Scholar
  49. Quill, T. E. (1993). The ambiguity of clinical intentions. New England Journal of Medicine, 329(14), 1039–1040.CrossRefGoogle Scholar
  50. Quill, T. E., & Cassel, C. K. (2003). Professional organizations’ position statements on physician-assisted suicide: A case for studied neutrality. Archives of Internal Medicine, 138, 208–211.Google Scholar
  51. Quill, T. E., Dresser, R., & Brock, D. W. (1997a). The rule of double effect – A critique of its role in end-of-life decision making. The New England Journal of Medicine, 337, 1768–1771.CrossRefGoogle Scholar
  52. Quill, T. E., Lo, B., & Brock, D. W. (1997b). Palliative options of last resort: A comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia. Journal of American Medical Association, 278, 2099–2104.CrossRefGoogle Scholar
  53. Rich, B. A. (2007). Causation and intent: Persistent conundrums in end-of-life care. Cambridge Quarterly of Health Care Ethics (Vol. 16, pp. 63–73).Google Scholar
  54. Rich, B. A. (2010). A patient’s guide to pain management. In T. Kushner (Ed.), Surviving health care (pp. 246–263). New York: Cambridge University Press.CrossRefGoogle Scholar
  55. Rich, B. A. (2012). Terminal suffering and the ethics of palliative sedation. Cambridge Quarterly of Health Care Ethics, 21, 30–39.CrossRefGoogle Scholar
  56. Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths – United States, 2010-2015. Center for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMRW), 65, 1445–1452.CrossRefGoogle Scholar
  57. SUPPORT Principal Investigators. (1995). A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses, preferences for outcomes, and risks of treatments (SUPPORT). Journal of American Medical Association, 274, 1591–1598.CrossRefGoogle Scholar
  58. Tomlinson v. Bayberry Care Center, et al. (2002). No. C 02-00120, Superior Court, Contra Costa Co, CA.Google Scholar
  59. Tolle, S. W., & Teno, J. M. (2017). Lessons from Oregon in embracing complexity in end-of-life care. New England Journal of Medicine, 376(11), 1078–1082.CrossRefGoogle Scholar
  60. Vacco v. Quill. (1997). 521 U.S. 793.Google Scholar
  61. Von Gunten, C. F. (2016). The pendulum swings for opioid prescribing. Journal of Palliative Medicine, 19(4), 348.CrossRefGoogle Scholar
  62. Wanzer, S. H., Federman, D. D., Adelsein, S. J., Cassel, C. K., Cassem, E. H., Cranford, R. E., et al. (1989). The physician’s responsibility toward hopelessly ill patients – A second look. New England Journal of Medicine, 320, 844–849.CrossRefGoogle Scholar
  63. Washington v. Glucksberg. (1997). 521 U.S. 702.Google Scholar
  64. Weissman, J. S., Cooper, Z., Hyder, J. A., Lipsitz, S., Jiang, W., Zinner, M. J., & Prigerson, H. G. (2016). End-of-life care intensity for physicians, lawyers, and the general population. JAMA, 315(3), 303–305.CrossRefGoogle Scholar
  65. Woodward, P. A. (Ed.). (2001). The doctrine of double effect – Philosophers debate a controversial moral principle. Notre Dame: Notre Dame University Press.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Davis Medical Center, University of CaliforniaSacramentoUSA

Personalised recommendations